Company intelligence
OPTIMA pharma
About OPTIMA pharma
The OPTIMA pharma Division offers customer-specific filling and processing solutions for the pharmaceutical, biotech and diagnostic industries – reliable and smart. It is an expert in filling and closing, containment and lyophilization of sophisticated pharmaceutical and diagnostic products and meets the requirements of its customers with a unique combination of application know-how, technological expertise as well as process and service quality. As an integrated system provider, Optima Pharma is the turnkey partner for complete lines, special solutions and sophisticated standard machines for pharmaceutical system technology. The filling line, isolator and freeze dryer come from a single source. OPTIMA pharma is part of the Optima Group based in Schwäbisch Hall, Germany Optima is a technology leader in the precise dosing, filling, packaging and handling of demanding liquid and solid products. With flexible and customer-specific filling, packaging and production systems, Optima has been ensuring for more than 100 years that valuable and sensitive goods such as medicines, hygiene and medical devices, food or cosmetics reach the people worldwide who depend on these products every day. With its global service network, Optima supports its customers' systems throughout the entire life cycle. More than 3,400 experts contribute to Optima's global success at its headquarters in Schwäbisch Hall and at over 20 locations in Germany and abroad. The common mission "We care for people" is in the foreground every day. OPTIMA pharma GmbH Otto-Hahn-Strasse 1 74523 Schwaebisch Hall · Germany Phone: +49 791 9495-0 Mail: pharma@optima-packaging.com Managing Director: Hans Bühler, Stephan Reuter, Dr. Johannes-Thomas Grobe Register court Stuttgart HRB 725110 VAT-No.: DE811566758 Verantwortlich für den Inhalt gemäß § 5 TMG: Hans Bühler Link to legal notice: https://www.optima-packaging.com/en/impressum
Verified activity
Signals from OPTIMA pharma
6 published signals
Products & Services
OPTIMA pharma introduced revised Annex 1 to environmental monitoring requirements, including continuous monitoring, minimizing manual interventions, reducing contamination risks, increasing transparency, and improving machine availability.
Reported by OPTIMA pharma
Presence & Recognition
OPTIMA pharma is exhibiting at the A3P International Congress 2026 in Biarritz at Booth 046
Reported by OPTIMA pharma
Presence & Recognition
OPTIMA pharma is hosting a 3-day lyophilization workshop on freeze-drying for biologics and pharmaceutics in Frankfurt from November 3 to 4, and a follow-up site visit to Optima Pharma in Mornshausen on November 5.
Reported by OPTIMA pharma
Research & Knowledge
OPTIMA pharma published a blog post detailing technical changes in aseptic production driven by EU-GMP Annex 1 requirements, including sterile transfers, first air, and reduced glove interventions.
Reported by OPTIMA pharma
Research & Knowledge
OPTIMA pharma conducted a detailed VPHP simulation to identify areas of high and low hydrogen peroxide saturation for pre-cycle development.
Reported by OPTIMA pharma
Products & Services
OPTIMA pharma introduced the OPTIMA FillCell to minimize product loss, enable the safe processing of CZ vials, and meet flexible production requirements.
Reported by OPTIMA pharma